Approval · Notice of Compliance 2696 · 1998
ACYCLOVIR SODIUM INJECTION: Notice of Compliance 2696
Issued March 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2696
- Date
- March 4, 1998
- Company
- Fujisawa Canada Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION | 02236926 | Marketed |
Medicinal ingredients
- ACYCLOVIR SODIUM 50 MG per ML